Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.41 is 23% above its 5-year average of -1.82, around the middle of its 5-year range (-3.57–-0.37).
8.46% below its 12-month average of -1.30.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.40.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.41
EARNINGS PER SHARE (EPS) AVG TTM
-1.30
EARNINGS PER SHARE (EPS) AVG 3Y
-2.00
EARNINGS PER SHARE (EPS) AVG 5Y
-1.82
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.46%
CURRENT VS 3Y AVG
+29.68%
CURRENT VS 5Y AVG
+22.53%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Pyxis Oncology, Inc.
Market Cap
$130.78M
Earnings Per Share (EPS)
-1.41
TTM Avg
-1.30
3Y Avg
-2.00
5Y Avg
-1.82
Market Cap
$132.64M
Earnings Per Share (EPS)
-3.68
TTM Avg
-1.85
3Y Avg
-2.09
5Y Avg
-2.42
Market Cap
$133.72M
Earnings Per Share (EPS)
-0.51
TTM Avg
-0.38
3Y Avg
-0.76
5Y Avg
-1.59
Market Cap
$133.33M
Earnings Per Share (EPS)
-0.18
TTM Avg
-0.17
3Y Avg
-0.17
5Y Avg
-0.09
Market Cap
$134.10M
Earnings Per Share (EPS)
0.45
TTM Avg
-0.23
3Y Avg
-0.84
5Y Avg
-0.86
Market Cap
$135.65M
Earnings Per Share (EPS)
-3.85
TTM Avg
-4.48
3Y Avg
-4.48
5Y Avg
-4.48
Market Cap
$126.21M
Earnings Per Share (EPS)
-0.74
TTM Avg
-1.87
3Y Avg
-2.08
5Y Avg
-2.08
Market Cap
$126.51M
Earnings Per Share (EPS)
-0.35
TTM Avg
-0.25
3Y Avg
-0.32
5Y Avg
-0.38
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | $130.78M | -1.41 | -1.30 | -2.00 | -1.82 |
| Health Catalyst, Inc. (HCAT)vs › | $132.64M | -3.68 | -1.85 | -2.09 | -2.42 |
| LifeMD, Inc. (LFMD)vs › | $133.72M | -0.51 | -0.38 | -0.76 | -1.59 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $133.33M | -0.18 | -0.17 | -0.17 | -0.09 |
| Organigram Global Inc. (OGI)vs › | $134.10M | 0.45 | -0.23 | -0.84 | -0.86 |
| Freenome, Inc. (FRNM)vs › | $135.08M | N/A | N/A | N/A | N/A |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.65M | -3.85 | -4.48 | -4.48 | -4.48 |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $126.21M | -0.74 | -1.87 | -2.08 | -2.08 |
| Entera Bio Ltd. (ENTX)vs › | $126.51M | -0.35 | -0.25 | -0.32 | -0.38 |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.98M | -13.24 | -14.57 | -14.57 | -81991.29 |
Trailing EPS (TTM)
$-1.41
Forward EPS (Est.)
$-1.22
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.28 |
| 2024-12-31 | -1.32 |
| 2023-12-31 | -1.85 |
| 2022-12-31 | -3.57 |
| 2021-12-31 | -2.53 |
| 2020-12-31 | -0.37 |
| 2019-12-31 | -0.08 |
